Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene - PubMed (original) (raw)
Comparative Study
. 2001 Sep 15;61(18):6640-8.
H Fujii, G Calin, H Mabuchi, M Negrini, Y Pekarsky, L Rassenti, H Alder, J C Reed, M J Keating, T J Kipps, C M Croce
Affiliations
- PMID: 11559527
Comparative Study
Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene
F Bullrich et al. Cancer Res. 2001.
Abstract
Chromosome 13q14 deletions constitute the most common genetic abnormality in chronic lymphocytic leukemia (CLL). To identify the putative tumor suppressor gene targeted by 13q14 genomic loss, we completely sequenced and characterized a segment of 790 kb at 13q14 spanning the minimal region of loss in CLL. Transcribed sequences in the region were identified through database homology searches and exon-prediction analysis. Two-hundred kb at the centromeric end of the sequence contain five CpG islands, three previously identified genes LEU5/RFP2, LEU2, and LEU1, seven of seven EST clusters composed of >10 ESTs, and a large number of predicted exons. Homology searches against the mouse EST database have allowed us to identify a highly conserved alternative first exon of the LEU2 gene, giving rise to a novel transcript, ALT1 (GenBank accession no. AF380424), which originates within a G+C region in the vicinity of the D13S272 marker. Two novel 3' exons of LEU2 were also identified and are present in both LEU2 and ALT1 transcripts. However, we have not identified any mutations in leukemia cases, or alterations in expression of mRNAs in the region, that might directly implicate these mRNAs in the pathology of CLL. The centromeric end of the sequence, where all reported genes are located, contains twice the expected amount of ALU repeats, whereas the telomeric end is LINE1 rich and contains four LINE1 elements longer than 4 kb, including two full-length LINE1 sequences. This feature of the sequence may favor the occurrence of chromosomal rearrangements and may confer instability to the region, resulting in deletions that may inactivate an as yet unidentified tumor suppressor.
Similar articles
- Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R. Migliazza A, et al. Blood. 2001 Apr 1;97(7):2098-104. doi: 10.1182/blood.v97.7.2098. Blood. 2001. PMID: 11264177 - Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.
Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grandér D, Iyengar A, Baranova A, Kashuba V, Merup M, Wu X, Gardiner A, Mullenbach R, Poltaraus A, Hultström AL, Juliusson G, Chapman R, Tiller M, Cotter F, Gahrton G, Yankovsky N, Zabarovsky E, Einhorn S, Oscier D. Liu Y, et al. Oncogene. 1997 Nov 13;15(20):2463-73. doi: 10.1038/sj.onc.1201643. Oncogene. 1997. PMID: 9395242 - Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia.
Rowntree C, Duke V, Panayiotidis P, Kotsi P, Palmisano GL, Hoffbrand AV, Foroni L. Rowntree C, et al. Leukemia. 2002 Jul;16(7):1267-75. doi: 10.1038/sj.leu.2402551. Leukemia. 2002. PMID: 12094250 - New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U, Dalla-Favera R. Klein U, et al. Semin Cancer Biol. 2010 Dec;20(6):377-83. doi: 10.1016/j.semcancer.2010.10.012. Epub 2010 Oct 26. Semin Cancer Biol. 2010. PMID: 21029776 Review. - Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.
Migliazza A, Cayanis E, Bosch-Albareda F, Komatsu H, Martinotti S, Toniato E, Kalachikov S, Bonaldo MF, Jelene P, Ye X, Rzhetsky A, Qu X, Chien M, Inghirami G, Gaidano G, Vitolo U, Saglio G, Resegotti L, Zhang P, Soares MB, Russo J, Fischer SG, Edelman IS, Efstratiadis A, Dalla-Favera R. Migliazza A, et al. Curr Top Microbiol Immunol. 2000;252:275-84. doi: 10.1007/978-3-642-57284-5_28. Curr Top Microbiol Immunol. 2000. PMID: 11125485 Review. No abstract available.
Cited by
- Microfluidic Device for On-Chip Immunophenotyping and Cytogenetic Analysis of Rare Biological Cells.
M Weerakoon-Ratnayake K, Vaidyanathan S, Larky N, Dathathreya K, Hu M, Jose J, Mog S, August K, K Godwin A, L Hupert M, A Witek M, A Soper S. M Weerakoon-Ratnayake K, et al. Cells. 2020 Feb 24;9(2):519. doi: 10.3390/cells9020519. Cells. 2020. PMID: 32102446 Free PMC article. - Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
Scaglione BJ, Salerno E, Balan M, Coffman F, Landgraf P, Abbasi F, Kotenko S, Marti GE, Raveche ES. Scaglione BJ, et al. Br J Haematol. 2007 Dec;139(5):645-57. doi: 10.1111/j.1365-2141.2007.06851.x. Epub 2007 Oct 17. Br J Haematol. 2007. PMID: 17941951 Free PMC article. Review. - Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia.
Kasar S, Salerno E, Yuan Y, Underbayev C, Vollenweider D, Laurindo MF, Fernandes H, Bonci D, Addario A, Mazzella F, Raveche E. Kasar S, et al. Genes Immun. 2012 Feb;13(2):109-19. doi: 10.1038/gene.2011.58. Epub 2011 Sep 1. Genes Immun. 2012. PMID: 21881595 Free PMC article. - Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.
Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, Lynch J, Watson P, Jansen M, Yoshinaga Y, Rosenquist R, de Jong PJ, Coggill P, Beck S, Lynch H, de la Chapelle A, Plass C. Raval A, et al. Cell. 2007 Jun 1;129(5):879-90. doi: 10.1016/j.cell.2007.03.043. Cell. 2007. PMID: 17540169 Free PMC article. - Using microRNA Networks to Understand Cancer.
Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA. Dragomir M, et al. Int J Mol Sci. 2018 Jun 26;19(7):1871. doi: 10.3390/ijms19071871. Int J Mol Sci. 2018. PMID: 29949872 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials